The rising prevalence in GLP-1 drugs for metabolic conditions has generated a discussion about delivery methods : transdermal systems versus tablets . Traditionally , GLP-1 treatments were exclusively available in oral form, but the development of patches provides a alternative option . Patches might benefit individuals facing challenges swallowing